| Stimulation*
|
---|
T cell Line/Ad Vector | None | Anti-CD3 | OVA peptide | PMA/Ionomycin |
---|
Th1+Ad5.UbP.GFP | 51% (117)a
| NDb
| ND | 54% (139) |
Th1+Ad5.CMV5.GFP | 20% (112) | 27% (212) | 45% (529) | 73% (1122) |
Th2+Ad5.UbP.GFP | 60% (212) | ND | ND | 70% (269) |
Th2+Ad5.CMV5.GFP | 43% (242) | 66% (1274) | 70% (753) | 75% (1421) |
-
*Th1 and Th2 lines derived from line 18 DO11.10/hCARΔcyt transgenic mice were transduced and GFP expression was analyzed as described in Fig. 4. The lines were activated by incubation on anti-CD3 coated plates (10 μg/ml), addition of irradiated BALB/c splenocytes and 5 μg/ml of OVA peptide or 50 ng/ml PMA and 5 μM ionomycin for 24 h at 37°C/5% CO2. aPercentage of GFP positive cells (and mean fluorescence intensity of the GFP positive population) are indicated. bND – not determined.